EDAP TMS of Lyon, France, has secured approximately $6.5 million to accelerate marketing efforts of its Ablatherm-HIFU in Europe.
EDAP manufactures high-intensity focused ultrasound (HIFU) for the treatment of prostate cancer. The company plans to target both physicians and patients over the next 30 months in its marketing effort.
By AuntMinnie.com staff writers
August 4, 2006
Related Reading
EDAP extends Japanese presence, names Laronze as VP, February 16, 2006
EDAP taps Varona as medical director, December 7, 2005
EDAP, Siemens partner in breast cancer treatment, March 29, 2000
Copyright © 2006 AuntMinnie.com